Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp Tissues

Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp Tissues

Background: The Platelet-Activating Factor (PAF)/receptor (PAFR) system is involved in asthma and allergic rhinitis; however, its role in chronic rhinosinusitis (CRS) is still unclear. This study aimed to assess the expression of PAFR and the concentration of Lyso-PAF isoforms in the nasal polyps (N...

Full description

Bibliographic Details
Main Authors:	Jordi Roca-Ferrer, Maria Pérez-González, Isam Alobid, Valeria Tubita, Mireya Fuentes, Marina Bantulà, Rosa Muñoz-Cano, Antonio Valero, Iñaki Izquierdo, Joaquim Mullol
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Journal of Clinical Medicine
Subjects:	platelet-activating factor platelet-activating factor receptor chronic rhinosinusitis with nasal polyps asthma NSAID-exacerbated respiratory disease Lyso-PAF
Online Access:	https://www.mdpi.com/2077-0383/12/23/7357

Similar Items

Consumption of Farmed Fish, Fed with an Olive-Pomace Enriched Diet, and Its Effect on the Inflammatory, Redox, and Platelet-Activating Factor Enzyme Profile of Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial
by: Filio Petsini, et al.
Published: (2022-07-01)

Inhibition of platelet-activating factor (PAF)-induced platelet aggregation by fatty acids from human saliva
by: Mary A. Smal, et al.
Published: (2022-05-01)

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
by: Eileen Deuster, et al.
Published: (2021-09-01)

<it>In vitro </it>anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin
by: Demopoulos Constantinos A, et al.
Published: (2011-07-01)

Molecular Docking, Drug likeness Studies and ADMET prediction of Flavonoids as Platelet-Activating Factor (PAF) Receptor Binding
by: Mohammed BOUACHRINE, et al.
Published: (2021-05-01)

Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy
by: Ildefonso Alves da Silva Junior, et al.
Published: (2018-10-01)

Inhibitory Effects of Phylligenin and Quebrachitol Isolated from Mitrephora vulpina on Platelet Activating Factor Receptor Binding and Platelet Aggregation
by: Khozirah Shaari, et al.
Published: (2010-11-01)

Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF
by: Vyala Hanumanthareddy Chaithra, et al.
Published: (2018-11-01)

Platelet activating factor levels and metabolism in tangier disease: a case study
by: Kolovou Vana, et al.
Published: (2012-07-01)

New Insights Into the Pathologic Roles of the Platelet-Activating Factor System
by: Jeffrey B. Travers, et al.
Published: (2021-03-01)

Plasmalogenic Lipid Analogs as Platelet-Activating Factor Antagonists: A Potential Novel Class of Anti-inflammatory Compounds
by: Pu Rong, et al.
Published: (2022-04-01)

Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor
by: Tong Gao, et al.
Published: (2018-10-01)

Antiplatelet Aggregation and Platelet Activating Factor (PAF) Receptor Antagonistic Activities of the Essential Oils of Five Goniothalamus Species
by: Juriyati Jalil, et al.
Published: (2010-07-01)

Upregulated pneumococcal adhesion molecule (platelet-activating factor receptor) may predispose COPD patients to community-acquired pneumonia
by: Shukla SD, et al.
Published: (2017-10-01)

Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase
by: Hugo C Castro Faria Neto, et al.
Published: (2005-03-01)

To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase
by: Gopal Kedihitlu Marathe, et al.
Published: (2014-09-01)

Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets
by: Moschos MM, et al.
Published: (2017-04-01)

Dissecting the Mechanism of Intracellular Mycobacterium smegmatis Growth Inhibition by Platelet Activating Factor C-16
by: Muhammad Suleman Riaz, et al.
Published: (2020-06-01)

Direct Growth Inhibitory Effect of Platelet Activating Factor C-16 and Its Structural Analogs on Mycobacteria
by: Muhammad S. Riaz, et al.
Published: (2018-09-01)

Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients
by: Rajendran Harishkumar, et al.
Published: (2022-10-01)

Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells
by: Eleni Botitsi, et al.
Published: (1998-06-01)

Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation
by: Alexandre Mansour, et al.
Published: (2020-07-01)

Selective inhibitors of a PAF biosynthetic enzyme lysophosphatidylcholine acyltransferase 2[S]
by: Megumi Tarui, et al.
Published: (2014-07-01)

Ozone and procaine increase secretion of platelet-derived factors in platelet-rich plasma
by: Chiara Rita Inguscio, et al.
Published: (2023-10-01)

Evaluation of factors affecting the quantity and quality of platelet-rich plasma and platelet-derived growth factor-BB
by: Rahul Verma, et al.
Published: (2021-01-01)

The Roles of Platelet-Activating Factor and Magnesium in Pathophysiology of Hypertension, Atherogenesis, Cardiovascular Disease, Stroke and Aging
by: Nilank Shah, et al.
Published: (2022-02-01)

Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study
by: Moschos MM, et al.
Published: (2016-12-01)

First-Row Transition Metal Complexes Incorporating the 2-(2′-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin
by: Antigoni Margariti, et al.
Published: (2023-10-01)

Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation
by: Nicolaos Androulakis, et al.
Published: (2005-09-01)

Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism
by: Paraskevi Detopoulou, et al.
Published: (2021-01-01)

Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth
by: Valerie A. Cruz Flores, et al.
Published: (2021-09-01)

Consumption of Enriched Yogurt with PAF Inhibitors from Olive Pomace Affects the Major Enzymes of PAF Metabolism: A Randomized, Double Blind, Three Arm Trial
by: Maria Detopoulou, et al.
Published: (2021-05-01)

Identification and <i>In Silico</i> Simulation on Inhibitory Platelet-Activating Factor Acetyl Hydrolase Peptides from Dry-Cured Pork Coppa
by: Mingming Li, et al.
Published: (2023-03-01)

Activation, function and content of platelets in burn patients
by: Roos E. Marck, et al.
Published: (2019-04-01)

Quantification of growth factors in different platelet concentrates
by: Jing Qiao, et al.
Published: (2017-11-01)

Consumption of yogurt enriched with polar lipids from olive oil by-products reduces platelet sensitivity against platelet activating factor and inflammatory indices: A randomized, double-blind clinical trial
by: Smaragdi Antonopoulou, et al.
Published: (2022-06-01)

Platelet-activating factor (PAF) enhances guinea pig detrusor smooth muscle contractile activities by stimulating voltage-dependent Ca2+ channels and store-operated Ca2+ channels
by: Keisuke Obara, et al.
Published: (2023-06-01)

Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated Groups
by: Jeong Woo Lee, et al.
Published: (2013-09-01)

Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated Groups
by: Jeong Woo Lee, et al.
Published: (2013-09-01)

Platelet-activating factor acetyl hydrolase IB2 dysregulated cell proliferation in ovarian cancer
by: YingYing He, et al.
Published: (2021-12-01)